Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
COX6A1 pseudogene 7 (COX6A1P7) is a non-coding genomic element categorized as a pseudogene of the functional COX6A1 gene, which codes for cytochrome c oxidase subunit 6A1, a critical component of Complex IV in the mitochondrial electron transport chain. Pseudogenes like COX6A1P7 are typically non-functional relics of genes and do not encode proteins. While some pseudogenes can impact gene regulation through non-coding RNA or serve as sequences for regulatory elements, there is currently no evidence that COX6A1P7 possesses any biological, therapeutic, or diagnostic significance. COX6A1P7 is not considered a therapeutic target or a receptor, enzyme, transporter, or other functional protein. No known diseases, drugs, or biomarkers are linked to this specific pseudogene. Pseudogenes can, in rare cases, have biological effects such as acting as microRNA sponges, influencing parental gene expression, or even becoming sources of regulatory non-coding RNAs, but these effects are specific and not described for COX6A1P7. If structured information is required for a bona fide therapeutic target, COX6A1P7 would not qualify.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on COX6A1 pseudogene 7 (COX6A1P7).